NYXH

Nyxoah SA Ordinary Shares
Data: 2026-01-30
$4.75
Price
-2.97%
Change
$11.87
52W High
$4.345
52W Low

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Quick Stats
Jan 30, 2026

51.6

AI Score

HOLD

0.93

Volume Ratio

Mar 12, 2026

Next Earnings

12

+ve Days (30d)

17

-ve Days (30d)

NYXH Stock Summary

Last updated Jan 30, 2026

NYXH is currently trading at $4.75, positioned below its 200-day moving average of $6.05, suggesting bearish momentum. The stock has a 52-week range of $4.345 to $11.87.

Technical Analysis: The 50-day moving average stands at $4.78, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 45.923, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.264, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NYXH at 51.6/100 with a HOLD recommendation.

NYXH (Nyxoah SA Ordinary Shares) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 45.923
CMF (20) -0.264
ROC (10) -7.767
ADX (14) 18.401
Indicator Value
MACD (12,26,9) -0.011
AROONOSC (14) -50.0
WILLAMS %R (14) -87.671
MFI (14) 55.014
NYXH Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NYXH Price vs Max Options Open Interest
NYXH Max Change In Options Open Interest

NYXH Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NYXH Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NYXH Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NYXH Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Nyxoah SA Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

NYXH Moving Averages Analysis

NYXH (Nyxoah SA Ordinary Shares) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 4.81
20 4.89
30 4.82
50 4.78
100 5.05
200 6.05

NYXH Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 219.5 million
Earnings/Share ($) -2.69
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.2994
EPS Estimate Next Year ($) -2.2528
WallStreet Target Price ($) 11.516
Most Recent Quarter